Penny Stock Under Re 1 with 100% Public Share Holding: Board Likely to Announce Bonus Shares!

Biogen Pharmachem Industries Limited has officially announced that a meeting of its Board of Directors is scheduled for Monday, March 23, 2026, at the company's registered office. The primary agenda for this session is to deliberate on the declaration and issuance of bonus shares, contingent upon compliance with all applicable statutory provisions. This strategic proposal remains subject to the final approval of the company's shareholders, marking a potential expansion of the firm's equity base and a significant update for its investors.

About the Company

Incorporated in 1995 and based in Rajkot, Biogen Pharmachem Industries Ltd (formerly Sun Techno Overseas Ltd) operates as a micro-cap company primarily involved in the trading of shares, securities, and various commodities, including agro-based products and precious metals. While its charter includes consulting services and wind power generation, the company has recently faced significant operational headwinds, often reporting zero revenue from core operations due to limited working capital.

Despite these challenges, the company showed signs of a financial turnaround in late 2025, reporting a net profit of Rs 0.46 crore for Q3 FY26, largely driven by "other income" rather than direct sales. As of February 2026, the management continues to seek new business opportunities to stabilise operations and has recently proposed a board meeting to consider the issuance of bonus shares.

The company has a market cap of over Rs 60 crore and 100 per cent stake is owned by public shareholders. The stock is trading under Re 1 and up by 21 per cent from its 52-week low of Re 0.57 per share.

Disclaimer: The article is for informational purposes only and not investment advice.